Health Care · Services-General Medical & Surgical Hospitals, NEC · Nasdaq · CIK 1638833 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $16.41Day +5.33%Mkt cap $2.1B1Y −26.5%Off 52W high −31.9%Vol (1Y) 47.7%
Daily closing price, split-adjusted to the current basis; 3y shown of 2,719 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Fair value (model)$34.14 |
| Implied upside+108.0% |
| Valuation confidenceLOW |
| Price impliesUNDEMANDING · 1.6% growth |
| Short interest11.3% of sh out |
| Days to cover11.4d |
| 13F net flow (QoQ)+0.61% |
| Top-10 13F concentration74.6% |
| Next report (est.)2026-08-10 |
Fair value, confidence and the reverse-DCF grade are the MATERIALIZED daily snapshot (the same columns the screener serves), not a live model run. Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$3.34B |
| Earnings (TTM)-$76.1M |
| YTD+6.2% |
| 1Y−26.5% |
| 3Y−57.5% |
| 5Y−70.3% |
| 10Y−9.5% |
| Since incept. (ann.)−0.9% |
Total return through 2026-07-29 · series begins 2015-10-01. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)47.7% |
| Ann. volatility (3Y)49.7% |
| Sharpe (1Y)−0.41 |
| Sharpe (3Y)−0.32 |
| Max drawdown (1Y)−51.8% |
| Max drawdown (3Y)−70.3% |
| Beta (3Y vs SPY)1.87 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Bain Capital Investors LLC | 49.9M | $595M | — | +0.0% |
| JANUS HENDERSON GROUP PLC | 13.5M | $161M | — | +0.0% |
| Pentwater Capital Management LP | 12.7M | $151M | — | +26.6% |
| KING STREET CAPITAL MANAGEMENT, L.P. | 10.2M | $122M | — | +0.0% |
| UBS Group AG | 10.2M | $121M | — | +30.6% |
| BlackRock, Inc. | 5.7M | $67M | — | −0.5% |
| DIMENSIONAL FUND ADVISORS LP | 5.3M | $63M | — | +7.9% |
| Clearbridge Investments, LLC | 4.1M | $49M | — | −2.6% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total. % of shares outstanding suppressed: the summed institutional 13F holdings (159,138,580) exceed the latest reported shares-outstanding count (130,788,162) by more than securities-lending double counting can explain (FINRA short interest 15,807,501 shares at 2026-04-30), so the share count is stale or wrong (common for annual 20-F foreign private issuers after a share issuance) and a percentage would be fabricated. Holder share counts are shown as filed.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-05 | −$0.28 | — | $810.9M | +4.5% |
| 2025-12-31 | 2026-03-02 | — | — | $885.0M | +2.4% |
| 2025-09-30 | 2025-11-10 | −$0.18 | — | $821.5M | +6.6% |
| 2025-06-30 | 2025-08-05 | −$0.02 | — | $826.2M | +8.4% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-10 is ESTIMATED from filing cadence (median gap 97d) — not company-confirmed.
Surgical Facilities 100%
business segments · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
| ROE−4.4% |
| Net margin−2.4% |
| Debt / equity2.18× |
| Total debt / EBITDA6.61× |
| Sales growth 3Y9.2% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
